Applying Dry Powder Coatings - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Applying Dry Powder Coatings
The authors experiment with a resonant acoustic mixer as a method for dry powder coating.


Pharmaceutical Technology
Volume 35, Issue 10, pp. 94-102

Acknowledgments

Thanks is given to Professor Rajesh Davé (New Jersey Institute of Technology) for his review, suggestions, and support.

Matthew P. Mullarney*, Beth A. Langdon, and Mark A. Polizzi are scientists in the dosage form development group at Pfizer, Eastern Point Rd, Groton, CT 06340, USA, tel. 860.715.4139, fax 860.441.3972,
. Lauren E. Beach, PhD, is currently a scientist in the pharmaceutical development group at Aprecia Pharmaceuticals.

*To whom all correspondence should be addressed.

Submitted: May 3, 2011. Accepted: June 24, 2011.

References

1. M.P. Mullarney et al., Powder Technol. 212 (3), 397–402 (2011).

2. R. Pfeffer et al., Powder Technol. 117 (1–2), 40–67 (2001).

3. M. Ramlakhan et al., Powder Technol. 112 (1–2), 137–148 (2000).

4. J. Tomas and S. Kleinschmidt, Chem. Eng. Technol. 32 (10), 1470–1483 (2009).

5. J. Yang et al., Powder Technol. 158 (1–3), 21–33 (2005).

6. D.K. Balachandran et al., Powder Technol., (in review).

7. H.W. Howe et al., "Apparatus and method for resonant-vibratory mixing," US patent 7,188,993, Jan. 2004.

8. H.W. Howe et al., "Method for Resonant-Vibratory Mixing," US patent 7,866,878, Jan. 2007.

9. A.W. Jenike, Storage and flow of solids: Bulletin No 123 of the Utah Engineering Experiment Station (University of Utah, Salt Lake City, UT, Ed. 16, Vol. 53, 1964),

10. A.K. Muller et al., Eur. J. Pharm. Sci. 34 (4–5), 303–308 (2008).

11. Q. Zhou et al., Powder Technol. 207 (1–3), 414–421 (2011).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here